Clin2
NCT06892197Possibly a fitRecruiting

Comparing two steroids for severe pneumonia

Community Acquired Pneumonia (CAP)

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial compares two common steroid medicines, hydrocortisone and prednisolone, to see which works better for people with severe community-acquired pneumonia. It aims to find the best treatment to help you recover faster.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
1,600 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • You have been diagnosed with severe pneumonia that developed outside of a hospital.
  • Your doctor has decided that you need steroid treatment for your pneumonia.
  • You have not been in the hospital for more than 24 hours before starting this trial.
  • You are not pregnant or breastfeeding.
  • You do not have active tuberculosis or a serious fungal infection, and your pneumonia was not caused by the flu.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06892210Recruiting· Phase 4
Steroid comparison for COPD flare-ups

This trial compares two common steroids, hydrocortisone and prednisolone, to see which works better for treating COPD flare-ups. It may help you recover faster from a sudden worsening of your breathing.

Rønne, Bornholm
NCT07357935Not yet recruiting· Phase 1/Phase 2
Steroid treatment for severe pneumonia in the ICU

This trial tests if giving steroids early, based on your immune system, can help treat severe pneumonia that needs ICU care. It aims to reduce inflammation and improve recovery.

NCT07152587Not yet recruiting· Phase 2/Phase 3
Testing targeted anti-inflammatory drugs for severe pneumonia in the ICU

This trial tests if anti-inflammatory drugs tailored to specific germs can help patients in the ICU with severe community-acquired pneumonia recover faster. You may be eligible if you've been in the ICU less than 48 hours and meet certain diagnostic criteria.

NCT07703098Not yet recruiting· Phase 4
Hydrocortisone vs Methylprednisolone for Steroid-Induced Adrenal Insufficiency

This trial compares two medications, hydrocortisone and methylprednisolone, to see which works better for people whose adrenal glands have stopped working properly after taking high doses of steroids (methylprednisolone) for more than 4 weeks.

Ljubljana
NCT07511582Recruiting· Phase 2
Steroids for severe breathing problems in the ICU

This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.

Beijing, Beijing Municipality
NCT07152613Not yet recruiting· Phase 3
Steroids for Pneumocystis pneumonia in ICU adults without HIV

This trial tests whether adding corticosteroids helps non-HIV immunocompromised adults with severe Pneumocystis pneumonia in the ICU. If you meet the criteria, you may be randomly assigned to receive either steroids plus standard care or standard care alone.

Hear when a new Community Acquired Pneumonia (CAP) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.